Vaxart Inc (VXRT)
0.7289
-0.02
(-2.68%)
USD |
NASDAQ |
May 03, 16:00
0.7419
+0.01
(+1.78%)
After-Hours: 20:00
Vaxart Cash from Investing (Quarterly): 15.10M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.10M |
| September 30, 2023 | 4.97M |
| June 30, 2023 | -1.583M |
| March 31, 2023 | 25.46M |
| December 31, 2022 | 15.80M |
| September 30, 2022 | -31.07M |
| June 30, 2022 | -8.875M |
| March 31, 2022 | 3.732M |
| December 31, 2021 | -8.177M |
| September 30, 2021 | -4.412M |
| June 30, 2021 | -15.95M |
| March 31, 2021 | -20.56M |
| December 31, 2020 | -0.902M |
| September 30, 2020 | -0.308M |
| June 30, 2020 | -0.009M |
| March 31, 2020 | -0.001M |
| December 31, 2019 | -0.012M |
| September 30, 2019 | -0.127M |
| June 30, 2019 | -0.159M |
| March 31, 2019 | -0.552M |
| December 31, 2018 | -0.195M |
| September 30, 2018 | -0.173M |
| June 30, 2018 | -0.199M |
| March 31, 2018 | 26.78M |
| December 31, 2017 | 14.50M |
| Date | Value |
|---|---|
| September 30, 2017 | 6.40M |
| June 30, 2017 | 4.90M |
| March 31, 2017 | -14.70M |
| December 31, 2016 | 1.30M |
| September 30, 2016 | 6.90M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -1.30M |
| December 31, 2015 | 2.80M |
| September 30, 2015 | -0.20M |
| June 30, 2015 | -16.70M |
| March 31, 2015 | 0.30M |
| December 31, 2014 | 6.90M |
| September 30, 2014 | -9.90M |
| June 30, 2014 | -9.90M |
| March 31, 2014 | -0.10M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -0.10M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | -0.001M |
| March 31, 2012 | 2.08M |
| December 31, 2011 | 2.052M |
| September 30, 2011 | 11.64M |
| June 30, 2011 | 27.72M |
| March 31, 2011 | 13.84M |
| December 31, 2010 | 17.60M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-31.07M
Minimum
Sep 2022
25.46M
Maximum
Mar 2023
-1.425M
Average
-0.159M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Novavax Inc | -9.078M |
| aTyr Pharma Inc | 17.82M |
| Allogene Therapeutics Inc | 67.46M |
| AIM ImmunoTech Inc | -0.214M |
| Protalix BioTherapeutics Inc | -0.342M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.52M |
| Cash from Financing (Quarterly) | -0.066M |
| Free Cash Flow | -72.32M |
| Free Cash Flow Per Share (Quarterly) | -0.0946 |
| Free Cash Flow to Equity (Quarterly) | -13.42M |
| Free Cash Flow to Firm (Quarterly) | -13.12M |
| Free Cash Flow Yield | -69.79% |